Financhill
Back

Vita 34 AG 10K Form

Sell
45

VTIAF
Vita 34 AG

Last Price:
5.99
Seasonality Move:
-16.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VTIAF News And Ratings

See the #1 stock for the next 7 days that we like better than VTIAF

VTIAF Financial Statistics

Sales & Book Value

Annual Sales: $83.43M
Cash Flow: $3.01M
Price / Cash Flow: 9.77
Annual Sales: $1.56
Price / Book: 3.85

Profitability

EPS (TTM): 0.15170
Net Income (TTM): $2.8M
Gross Margin: $30.58M
Return on Equity: 12.62%
Return on Assets: 1.65%

Vita 34 AG Earnings Forecast

Key Vita 34 AG Financial Ratios

  • The Gross Profit Margin over the past 18 years for VTIAF is 36.65%.
  • The Selling, General & Administrative Expenses for VTIAF have been equal to 17.54% of Gross Profit Margin.
  • The Research & Development expenses have been 5.59% of Revenue.
  • The Interest Expense is -62.73% of Operating Income.
  • The Net Earning history of VTIAF is -2.42% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

Vita 34 AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: VTIAF
Website: vita34.de

Debt

Debt-to-Equity Ratio: 0.25
Current Ratio: 0.76
Quick Ratio: 0.7

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VTIAF Technical Analysis vs Fundamental Analysis

Sell
45
Vita 34 AG (VTIAF) is a Sell

Is Vita 34 AG a Buy or a Sell?

  • Vita 34 AG stock is rated a Sell
    The current Vita 34 AG [VTIAF] share price is $5.99. The Score for VTIAF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.